Journals / Osmangazi Tıp Dergisi / 2026 / Cilt: 48 Sayı: 3

Lactate/Albumin Ratio as a Simple Prognostic Biomarker in Acute COPD Exacerbations Presenting to the Emergency Department

Acil Servise Başvuran Akut KOAH Alevlenmelerinde Basit Bir Prognostik Biyobelirteç Olarak Laktat/Albümin Oranı

Fatih Alper Ayyıldız(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ESKİŞEHİR ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, ACİL TIP ANABİLİM DALI)0000-0002-2502-1030
Göknur Yıldız(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ESKİŞEHİR ŞEHİR SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, ACİL TIP ANABİLİM DALI)0000-0002-2097-2531
Pages
442–448
Publication Date
2026-05-12
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further prospective studies are needed to define its optimal use in clinical decision-making.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Acute exacerbations of chronic obstructive pulmonary disease (COPD) are a major cause of hospitalization and mortality worldwide, and early identification of high-risk patients in the emergency department is critical for optimizing clinical management.
📊
Key Findings & Data:This retrospective study aimed to evaluate the prognostic value of LAR in patients admitted with acute COPD exacerbation and to compare its performance with established clinical scoring systems.
💡
Conclusion & Impact:Further prospective studies are needed to define its optimal use in clinical decision-making.
🔬Design:Araştırma Makalesi
📍Scope:2024 Verileri
⚙️Variables:Kronik obstrüktif akciğer hastalığı · Laktat-albümin oranı · Acil servis

Abstract

Acute exacerbations of chronic obstructive pulmonary disease (COPD) are a major cause of hospitalization and mortality worldwide, and early identification of high-risk patients in the emergency department is critical for optimizing clinical management. The lactate-to-albumin ratio (LAR) has recently gained attention as a simple biochemical marker reflecting both metabolic stress and systemic inflammation. This retrospective study aimed to evaluate the prognostic value of LAR in patients admitted with acute COPD exacerbation and to compare its performance with established clinical scoring systems. A total of 721 patients aged 18 years or older who were hospitalized after presenting to the emergency department with a confirmed diagnosis of COPD exacerbation between September 2024 and September 2025 were included. Demographic, clinical, and laboratory variables were recorded, and LAR, Pneumonia Severity Index (PSI), and CURB-65 scores were calculated at admission. The primary outcome was intensive care unit (ICU) admission, and secondary outcomes included endotracheal intubation and in-hospital mortality. LAR levels were significantly higher in patients who required ICU care, intubation, or subsequently died, and increasing LAR values were associated with adverse outcomes. Although PSI and CURB-65 demonstrated superior discriminative power compared with LAR, the ratio provided a moderately sensitive indicator of clinical deterioration. These findings suggest that LAR, a readily accessible and inexpensive laboratory parameter, may serve as a complementary adjunct for early risk stratification in acute COPD exacerbations. Further prospective studies are needed to define its optimal use in clinical decision-making.

Özet

Kronik obstrüktif akciğer hastalığının (KOAH) akut alevlenmeleri dünya genelinde hastaneye yatış ve mortalite oranlarının başlıca nedenleri arasındadır ve acil serviste yüksek riskli hastaların erken dönemde tanımlanması uygun klinik yönetim açısından büyük önem taşımaktadır. Laktat/albumin oranı (LAR), metabolik stres ile sistemik inflamasyonu birlikte yansıtan basit bir biyokimyasal belirteç olarak son yıllarda dikkat çekmektedir. Bu retrospektif çalışmanın amacı, akut KOAH alevlenmesi nedeniyle hastaneye yatırılan hastalarda LAR’ın prognostik değerini değerlendirmek ve bu oranın performansını mevcut klinik skorlama sistemleriyle karşılaştırmaktır. Çalışmaya Eylül 2024–Eylül 2025 tarihleri arasında acil servise başvuru sonrası KOAH alevlenmesi tanısı doğrulanan ve 18 yaş üzerindeki toplam 721 hasta dahil edilmiştir. Hastaların demografik, klinik ve laboratuvar verileri kaydedilmiş; başvuru anında LAR, Pnömoni Şiddet İndeksi (PSI) ve CURB-65 skorları hesaplanmıştır. Birincil sonlanım yoğun bakım ünitesine (YBÜ) yatış olup, ikincil sonlanımlar entübasyon gereksinimi ve hastane içi mortalitedir. LAR düzeylerinin YBÜ’ye yatışı, entübasyonu ve mortaliteyi öngörmede anlamlı derecede yüksek olduğu, artan LAR değerleriyle kötü klinik sonuçların daha sık görüldüğü belirlenmiştir. PSI ve CURB-65’in ayırt edici gücü LAR’dan üstün olmakla birlikte, LAR’ın klinik kötüleşmeyi belirlemede orta düzeyde duyarlılık gösterdiği görülmüştür. Bulgularımız, kolay erişilebilir ve düşük maliyetli bir parametre olan LAR’ın akut KOAH alevlenmelerinde erken risk sınıflandırmasında tamamlayıcı bir belirteç olarak kullanılabileceğini düşündürmektedir. Klinik uygulamadaki yerinin netleştirilmesi için prospektif çalışmalara ihtiyaç vardır.

🔖

Cite This Article

Ayyıldız, F. A., Yıldız, G. (2026). Lactate/Albumin Ratio as a Simple Prognostic Biomarker in Acute COPD Exacerbations Presenting to the Emergency Department. Osmangazi Tıp Dergisi, Cilt: 48 Sayı: 3, 442–448. https://doi.org/10.20515/otd.1825998

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (20)

  1. Barnes PJ. Inflammatory mechanisms in chronic obstructive pulmonary disease. Eur Respir J. 2020;56(5):2000382.
  2. World Health Organization. Global health estimates: COPD mortality. WHO; 2023.
  3. Roca O, Gómez S, Masclans JR, et al. ICU outcomes in COPD exacerbations requiring ventilatory support. Chest. 2022;161(3):745-756.
  4. Phua J, Amakawa K, Nishimura M, et al. Prognostic markers in respiratory critical care: beyond lactate. Ann Intensive Care. 2023;13(1):51-59.
  5. Cecconi M, De Backer D, Antonelli M, et al. Pathophysiology and clinical meaning of hyperlactatemia. Intensive Care Med. 2022;48(6):724-737.
  6. MacDonald MI, Polkinghorne KR, MacDonald CJ, et al. Elevated blood lactate in COPD exacerbations associates with adverse clinical outcomes. Respirology. 2023;28(9):860-868.
  7. Kangelaris KN, Ware LB, Calfee CS, et al. Biomarkers of hypoxia and inflammation in acute respiratory failure. Crit Care. 2023;27(1):92.
  8. Ling M, Huiyin L, Shanglin C, et al. Relationship between human serum albumin and in-hospital mortality in critical care patients with chronic obstructive pulmonary disease. Front Med (Lausanne). 2023;10:1109910.
  9. Chen W, Ye XY, Li Z, et al. Association between serum albumin and mortality in COPD: a systematic review. Int J Chron Obstruct Pulmon Dis. 2022;17:3221-3230.
  10. Huang Y, Chen X, Zhou W, et al. Prognostic impact of albumin in COPD-related hospitalizations. Respir Med. 2023;205:107078.
  11. Teboul JL. Clinical interpretation of lactate: what we know (and what we don’t). Crit Care. 2023;27(4):187.
  12. Zhang Z, Chen L, Ni H, et al. Lactate/albumin ratio as a prognostic marker in critical illness: a meta-analysis. Sci Rep. 2024;14:12245.
  13. Yoon SH. Using the lactate-to-albumin ratio to predict mortality in critical illness: a review. Eur Rev Med Pharmacol Sci. 2022;26:1743-1752.
  14. Liu Y, Zhang Y, Li F, et al. Lactate/albumin ratio as a predictor of 28-day mortality in emergency department sepsis patients. Am J Emerg Med. 2022;56:144-151.
  15. Lee YH, Kim J, Park SY, et al. Prognostic value of lactate/albumin ratio in sepsis and respiratory failure. Crit Care Med. 2024;52(1):e44-e53.
  16. Calle Rubio M, Lopez-Campos JL, Soler-Cataluña JJ, et al. Predictive scores in COPD exacerbations: strengths and limitations. Eur Respir J. 2021;58(6):2100967.
  17. Zhao K, Zhou L, Ni Y, et al. Association between lactate-to-albumin ratio and 28-day all-cause mortality in critical care patients with COPD. Int J Chron Obstruct Pulmon Dis. 2025;20:1419-1434.
  18. Ding C, Wu X, Chen R, et al. Lactate dehydrogenase to albumin ratio and outcomes in acute exacerbation of COPD. BMC Pulm Med. 2025;25:186.
  19. Barkati M, Bouabid S, El Ghazoui A, et al. Early warning biomarkers in COPD exacerbations. Clin Respir J. 2024;18:201-211.
  20. Liang C, Zhang Z, Wang G, et al. Lactate/albumin ratio predicts mortality in critically ill patients. Sci Rep. 2025;15:1842.